Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

Authors:

Abstract
Evaluating COVID-19 vaccine effectiveness (VE) domestically is crucial for assessing and determining national vaccination policy. This study aimed to evaluate VE of mRNA COVID-19 vaccines in Japan....
Funding Information
  • Japan Agency for Medical Research and Development (JP21fk0108612)
  • Ministry of Health, Labour and Welfare

This publication has 29 references indexed in Scilit: